Peginterferon Lambda-1a (Lambda) Compared to Peginterferon Alfa-2a (Alfa) in Treatment-Naive Patients With HCV Genotypes (GT) 1 or 4: SVR24 Results From EMERGE Phase 2b
Publication
, Conference
Muir, AJ; Hillson, JL; Gray, TE; Xu, D; Ishak, L; Freeman, JA; Fontana, D; Horga, A; Lopez-Talavera, JC
Published in: HEPATOLOGY
October 1, 2012
Duke Scholars
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
October 1, 2012
Volume
56
Start / End Page
299A / 299A
Location
Boston, MA
Publisher
WILEY-BLACKWELL
Conference Name
63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Muir, A. J., Hillson, J. L., Gray, T. E., Xu, D., Ishak, L., Freeman, J. A., … Lopez-Talavera, J. C. (2012). Peginterferon Lambda-1a (Lambda) Compared to Peginterferon Alfa-2a (Alfa) in Treatment-Naive Patients With HCV Genotypes (GT) 1 or 4: SVR24 Results From EMERGE Phase 2b. In HEPATOLOGY (Vol. 56, pp. 299A-299A). Boston, MA: WILEY-BLACKWELL.
Muir, Andrew J., Jan L. Hillson, Todd E. Gray, Dong Xu, Laura Ishak, Jeremy A. Freeman, David Fontana, Arantxa Horga, and Juan Carlos Lopez-Talavera. “Peginterferon Lambda-1a (Lambda) Compared to Peginterferon Alfa-2a (Alfa) in Treatment-Naive Patients With HCV Genotypes (GT) 1 or 4: SVR24 Results From EMERGE Phase 2b.” In HEPATOLOGY, 56:299A-299A. WILEY-BLACKWELL, 2012.
Muir AJ, Hillson JL, Gray TE, Xu D, Ishak L, Freeman JA, et al. Peginterferon Lambda-1a (Lambda) Compared to Peginterferon Alfa-2a (Alfa) in Treatment-Naive Patients With HCV Genotypes (GT) 1 or 4: SVR24 Results From EMERGE Phase 2b. In: HEPATOLOGY. WILEY-BLACKWELL; 2012. p. 299A-299A.
Muir, Andrew J., et al. “Peginterferon Lambda-1a (Lambda) Compared to Peginterferon Alfa-2a (Alfa) in Treatment-Naive Patients With HCV Genotypes (GT) 1 or 4: SVR24 Results From EMERGE Phase 2b.” HEPATOLOGY, vol. 56, WILEY-BLACKWELL, 2012, pp. 299A-299A.
Muir AJ, Hillson JL, Gray TE, Xu D, Ishak L, Freeman JA, Fontana D, Horga A, Lopez-Talavera JC. Peginterferon Lambda-1a (Lambda) Compared to Peginterferon Alfa-2a (Alfa) in Treatment-Naive Patients With HCV Genotypes (GT) 1 or 4: SVR24 Results From EMERGE Phase 2b. HEPATOLOGY. WILEY-BLACKWELL; 2012. p. 299A-299A.
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
October 1, 2012
Volume
56
Start / End Page
299A / 299A
Location
Boston, MA
Publisher
WILEY-BLACKWELL
Conference Name
63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics